Navigation Links
Intellect Neurosciences, Inc. Grants License for Certain Patents and Patent Applications to Wyeth and Elan Pharma International Ltd.
Date:5/19/2008

NEW YORK, May 19 /PRNewswire-FirstCall/ -- Intellect Neurosciences, Inc. (OTC Bulletin Board: ILNS), a biopharmaceutical company focused on development of disease-modifying therapeutic agents for the treatment and prevention of Alzheimer's disease (AD), announced today that it has entered into a license agreement with Wyeth (NYSE: WYE) and Elan Pharma International Ltd. ("Elan") regarding certain of Intellect's patents and patent applications related to antibodies and methods of treatment for Alzheimer's disease. Under the terms of the agreement, Wyeth and Elan may pay Intellect potential future milestone payments and royalties based on sales of potential products, if it is determined that they are covered by patents that issue from Intellect's patent applications.

Dr. Chain, Intellect's Chairman and CEO and inventor of the licensed patents and patent applications, commented: "We are delighted to enter into this licensing agreement, which provides Intellect a share in the future success of potential Wyeth and Elan products while we continue to develop our proprietary monoclonal antibodies for the treatment of AD."

About Alzheimer's disease

Alzheimer's disease, the most common form of dementia, is characterized by progressive loss of memory and cognition, ultimately leading to complete debilitation and death. A hallmark feature of Alzheimer's pathology is the presence of insoluble protein deposits known as beta-amyloid on the surface of nerve cells, which results from the accumulation of soluble beta-amyloid in the brain. The effects of the disease are devastating to the patients as well as the caregivers, with significant associated health care costs. It is estimated that there are over 12 million people suffering from
'/>"/>

SOURCE Intellect Neurosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. IC Sciences Announces Launch of ICS Advisory Services Intellectual Property Platforms Available Through ICSciences Alliance
2. Rosetta Genomics Announces Expansion of its MicroRNA Intellectual Property Estate
3. Intellect Neurosciences, Inc. Receives Notice of Allowance and Completes Grant Requirements for Pivotal European Patent Related to Passive Immunization of Alzheimers Disease
4. Intradigm Licenses Key Next Generation RNA Interference (RNAi) Intellectual Property From University of Massachusetts Medical School
5. ActivBiotics Intellectual Property Assets, Including Drug Product Candidates, Sold for $3.5 Million
6. Amarin Secures Global Intellectual Property Rights for Lipid Programs
7. ActivBiotics Completes Sale of Fixed Assets; Expands Due Diligence Initiative for the Sale of Intellectual Property, Including Drug Product Candidates
8. Nastech Assigns Intellectual Property Related to the Development of RNA-Based Therapeutics to its Subsidiary, MDRNA, Inc.
9. Intellect Neurosciences, Inc. Obtains Validation of European Patent for Alzheimers Vaccine in 19 Countries
10. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
11. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...in German . , Whether it,s CD packaging, co... Frequency Identification) are increasingly findin...ble to label objects or goods and identify them au...anner can read and process the data contained in t...er production conditions of up to 100 degrees Cels...
(Date:11/24/2009)...assador to also Visit Detroit , ...d Appia, French Ambassador for International Inves...e Agency, , , , ,What: Ambassador Appia is availa...ess initiatives adopted by France to further devel...r innovation and development., , ,When: Available ...
(Date:11/24/2009)...alif., Nov. 24 Two more prestigiou...nation,s leading online job board and careers site...n and Columbia University are now members of the j...ning Institutions. ,, The job board, www.bioca... life sciences. While there are hundreds of life s...
(Date:11/24/2009)...REYKJAVIK, Iceland, November 24 /PRNewswire-FirstC...y announced that it has received notice from,the N...ommon stock will be,suspended as of November 30, 2...ities and Exchange Commission, which will remove d...s the company files an appeal to the Nasdaq,Listin...
Breaking Biology Technology:Intelligence inside metal components 2Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3
...BOLZANO, Italy, April 14 Health Robotics today an... 31, 2008, delivering record levels,of firm purcha...Revenues in FY2008 were EUR8.2 million, a 161% inc...d and enjoy the benefits of its indirect,sales-cha...ition, zero debt,financing, worldwide adoption of ...
... Virus-like Particle (VLP) Vaccine Candidate Based...ce and Ferrets Against the Spanish Flu and Highly ...ril 14 /PRNewswire-FirstCall/ -- Novavax, In...udy results showing that an investigational H1N1 v... Spanish influenza strain protected against both t...
...JOSEPH, Mich., April 14 GeneGo, Inc., the leading...at Professor Marcelo Bento Soares of Children,s Me...Stem Cell Partnership Program. The goal of the pr...maps for adult, embryonic, fetal, fibroblasts, hem...pluripotent and totipotent stem cells. , , "We fe...
Other Biology Technology:Health Robotics Reports Triple-Digit-Growth Across All Financial Metrics in Fiscal Year 2008 2Health Robotics Reports Triple-Digit-Growth Across All Financial Metrics in Fiscal Year 2008 3Health Robotics Reports Triple-Digit-Growth Across All Financial Metrics in Fiscal Year 2008 4Health Robotics Reports Triple-Digit-Growth Across All Financial Metrics in Fiscal Year 2008 5NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains 2NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains 3NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains 4NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains 5Children's Memorial Research Center, Chicago Becomes a Member of GeneGo's MetaMiner Stem Cell Partnership Program 2
(Date:11/25/2009)...rofessors recently received funding from the Natio...beneficial to understanding the environment. The t...ood, assistant professor in the Department of Biol... separate research projects. , His first project... and Functions from the Leaf to the Landscape," wi...
(Date:11/24/2009)...escribed by traditional healers in Brazil to treat...in to fever and flu. , Now for the first time, re...o scientifically prove the pain relieving properti...an mint. , Testing this ancient South American he...cha was able to show that when prepared as a ,tea,...
(Date:11/24/2009)...o understanding how sounds associated with Navy so...r if they hear it at all. , The same type of lar...to detect flaws in the space shuttle,s behemoth so...k inside the giant head of a whale. The scans are ... whale,s hearing anatomy using a breakthrough meth...
Breaking Biology News(10 mins):Kent State University professors focus research on the environment with grants totaling $890,000 2Got a pain? -- Have a cup of Brazilian mint 2Rocket science leads to new whale discovery 2DOR BioPharma Receives FDA Orphan Drug Designation for orBec 28R 29 for the Treatment of Chronic Gastrointestinal GVHD 13343 1DOR BioPharma Receives FDA Orphan Drug Designation for orBec 28R 29 for the Treatment of Chronic Gastrointestinal GVHD 13343 2DOR BioPharma Receives FDA Orphan Drug Designation for orBec 28R 29 for the Treatment of Chronic Gastrointestinal GVHD 13343 3DOR BioPharma Receives FDA Orphan Drug Designation for orBec 28R 29 for the Treatment of Chronic Gastrointestinal GVHD 13343 4DOR BioPharma Receives FDA Orphan Drug Designation for orBec 28R 29 for the Treatment of Chronic Gastrointestinal GVHD 13343 5DOR BioPharma Receives FDA Orphan Drug Designation for orBec 28R 29 for the Treatment of Chronic Gastrointestinal GVHD 13343 6High cholesterol in midlife raises risk of late life dementia Kaiser Permanente study finds 53591 1High cholesterol in midlife raises risk of late life dementia Kaiser Permanente study finds 53591 2High cholesterol in midlife raises risk of late life dementia Kaiser Permanente study finds 53591 3Motorcyclist Lives On Rides On Through Organ Donation 53587 1Motorcyclist Lives On Rides On Through Organ Donation 53587 2Motorcyclist Lives On Rides On Through Organ Donation 53587 3Motorcyclist Lives On Rides On Through Organ Donation 53587 4Motorcyclist Lives On Rides On Through Organ Donation 53587 5
...ray-on films developed by UC San Diego chemists wi...ly reveal trace amounts of nitrogen-based explosiv...s on the films, which glow blue under ultraviolet ...fferent classes of explosive chemicals, a property..., or prevent one. , A recent episode of CSI: Miam...
...ing to a report from a CSIRO Wealth From Oceans Fl...ournal Geophysical Research Letters since 1950 Vi...n rainfall (March to May) compared to the average ...SIROs Dr Wenju Cai and Tim Cowan, say that the dec...s for about half of the total seasonal reduction.,...
... 25, 2008, approaching 5 p.m. PDT, NASA scientists...? , That,s because at that time the Phoenix Mars ... three legs to make a soft landing onto the northe... no valley is actually green on the Red Planet. Th... Mars Reconnaissance Orbiter,s HiRISE instrument. ...
Other Biology News:Glowing films developed by UC San Diego chemists reveal traces of explosives 2Understanding autumn rain decline in SE Australia 2Phoenix mission to Mars will search for climate clues 2Phoenix mission to Mars will search for climate clues 3
Multiskan EX from Thermo Scientific
...ti-tasking vacuum source and solvent recovery syst...and a maintenance-free, oil-free vacuum pump in a ...h glass condensation flask collects all the recove... UVS400 provides an ideal vacuum system for use wi...
Mouse Anti-Ubiquitin, Multi Monoclonal Antibody, Unconjugated, Clone FK2 from Assay Designs/Stressgen Bioreagents
Goat Anti-Lysozyme C (W-20) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Biology Products: